These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 179263)

  • 1. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system.
    Ohama E; Ikuta F
    Acta Neuropathol; 1976 Apr; 34(4):311-9. PubMed ID: 179263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amine accumulation: a possible precursor of Lewy body formation in Parkinson's disease.
    Sandyk R; Willis GL
    Int J Neurosci; 1992 Sep; 66(1-2):61-74. PubMed ID: 1304571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presenile dementia with Alzheimer-, Pick- and Lewy-body changes.
    Kosaka K; Oyanagi S; Matsushita M; Hori A
    Acta Neuropathol; 1976 Nov; 36(3):221-33. PubMed ID: 188300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia and Parkinson's disease--pathological and neurochemical considerations.
    Quinn NP; Rossor MN; Marsden CD
    Br Med Bull; 1986 Jan; 42(1):86-90. PubMed ID: 3006860
    [No Abstract]   [Full Text] [Related]  

  • 7. Lewy bodies in the enteric nervous system in Parkinson's disease.
    Wakabayashi K; Takahashi H; Takeda S; Ohama E; Ikuta F
    Arch Histol Cytol; 1989; 52 Suppl():191-4. PubMed ID: 2554944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meige syndrome in the spectrum of Lewy body disease.
    Mark MH; Sage JI; Dickson DW; Heikkila RE; Manzino L; Schwarz KO; Duvoisin RC
    Neurology; 1994 Aug; 44(8):1432-6. PubMed ID: 8058144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease.
    Pappolla MA; Shank DL; Alzofon J; Dudley AW
    Hum Pathol; 1988 Jan; 19(1):27-31. PubMed ID: 2447008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease with widespread presence of Lewy bodies.
    Mitsuyama Y; Fukunaga H; Yamashita M
    Folia Psychiatr Neurol Jpn; 1984; 38(1):81-8. PubMed ID: 6100367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells.
    Kupsky WJ; Grimes MM; Sweeting J; Bertsch R; Cote LJ
    Neurology; 1987 Jul; 37(7):1253-5. PubMed ID: 3037441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of sporadic Parkinson's disease].
    Braak H; Del Tredici K
    Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S2-4. PubMed ID: 20195936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with Lewy bodies: neuropathology.
    Dickson DW
    J Geriatr Psychiatry Neurol; 2002; 15(4):210-6. PubMed ID: 12489917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
    J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amine accumulation in Parkinson's disease and other disorders.
    Willis GL
    Neurosci Biobehav Rev; 1987; 11(1):97-105. PubMed ID: 2952907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rostral mesencephalon in Parkinson's disease and Alzheimer's disease.
    Hunter S
    Acta Neuropathol; 1985; 68(1):53-8. PubMed ID: 2996284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
    Kawamura M; Sato S; Matsumoto G; Fukuda T; Shiba-Fukushima K; Noda S; Takanashi M; Mori N; Hattori N
    Neurosci Lett; 2019 Apr; 699():59-63. PubMed ID: 30684677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease.
    Gibb WR; Lees AJ
    Neuropathol Appl Neurobiol; 1989; 15(1):27-44. PubMed ID: 2542825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.